FDA Requires New Eye-Risk Warnings on GLP-1 Drugs
The agency is calling for labels to flag a possible link to a rare eye condition, though a causal relationship has not been established.
Makkler Newsroom · Nov 10, 02:58 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $1,501.06 (+4.0%)
Prices may be delayed and are for informational purposes only - not investment advice.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.